Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Clinical and Laboratory Assessment of Visceral Leishmaniasis to Develop Clinical Prognostic Tools to Predict Relapse: a Prospective Cohort Study in Ethiopia

NCT05602610 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT05602610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05602610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Clinical and Laboratory Assessment of Visceral Leishmaniasis to Develop Clinical Prognostic Tools to Predict Relapse: a Prospective Cohort Study in Ethiopia
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2023
Completion date
June 30, 2027
Enrollment
741 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis